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Summary 
The  association  of PTPIC  deficiency with  the  multiplicity  of lymphoid  cell abnormalities 
manifested by motheaten (me)  and viable motheaten (me  9  mice suggests  a pivotal role for this 
tyrosine phosphatase in the regulation of lymphocyte differentiation and function. To delineate 
the relevance of PTP1C to T  cell physiology, we have examined me and me  ~ T  cells with re- 
gards  to  their  capacity to  transduce  activating  signals  through  the  T  cell  antigen  receptor 
(TCR).  Although  thymocyte maturation  appeared  normal  in  the  mutant  mice,  both  thy- 
mocytes and peripheral T  cells from these animals  exhibited proliferative responses to TCR 
stimulation that were markedly increased relative to those elicited in normal cells. Compared to 
normal thymocytes, PTP1C-deficient thymocytes also showed increased constitutive tyrosine 
phosphorylation of the TCR complex and enhanced and prolonged TCR-induced tyrosine 
phosphorylation of the TCR-~ and CD3-e, as well as a number of cytosolic proteins, most no- 
tably a 38-kD phosphoprotein found to associate  with the Grb2 adaptor SH2 domain in acti- 
vated thymocytes. These latter phosphoproteins also  associated with the Vav guanine nucle- 
otide  exchange  factor  upon  TCR  ligation,  and  were  dephosphorylated  by  recombinant 
PTP1C in vitro. In conjunction with the finding of PTP1C-TCR association in unstimulated 
normal thymocytes, these results reveal the capacity of PTP1C to interact with and likely de- 
phosphorylate resting and activated TCR complex components, as well as more distal signaling 
effectors that are normally recruited to the Vav and Grb2 SH2 domains after TCR stimulation. 
These data therefore strongly implicate PTP1C in the downregnlation of TCR signaling ca- 
pacity and,  taken together with the aberrant prolongation of TCR-induced, mitogen-associ- 
ated kinase  (MAPK) activation observed in PTP1C-deficient thymocytes, these findings sug- 
gest that the inhibitory influence of PTP1C on TCR signal relay is realized through its effects 
on both the TCR complex and downstream signaling elements that couple the activated anti- 
gen receptor to the Ras/MAPK response pathway. 
T 
he intracellular events linking TCR engagement to  a 
physiologic response involve a multiplicity of molecu- 
lar interactions, the specificity and sequelae of  which depend 
on the cell's developmental stage and exposure to costimu- 
latory signals.  Although the precise amalgam of molecular 
events that translate TCR engagement to specific types of 
cell behavior remain unclear,  a wealth of information has 
accrued  with  respect  to  the  general  molecular  strategies 
used to couple the stimulated TCR to the nucleus. As for 
other growth receptors, the downstream propagation of ac- 
tivation signals from the TCR is known to be critically de- 
pendent on tyrosine phosphorylation, both TCR compo- 
nents and numerous cytosolic signaling effectors becoming 
rapidly phosphorylated after TCR stimulation (1).  In con- 
trast  to many growth factors, however, the  signaling  ele- 
ments within  the  TCR  complex lack intrinsic  enzymatic 
activity, and their tyrosine phosphorylation is thus achieved 
through interactions with nonreceptor protein tyrosine ki- 
nases  (PTKs) ~,  most  notably  ZAP-70,  syk,  and  the  src- 
related  ick  and  fyn proteins  (2,  3).  The  effects of these 
PTKs  on  TCR  signaling  capacity primarily reflects their 
phosphorylation oftyrosine residues mapping within highly 
conserved domains (tyrosine-based activation motifs) of the 
TCR-CD3-e,  ~ and ~  subunits with the consequent gen- 
eration of high affinity binding sites for the recruitment of 
SH2 domain-containing effectors into the activation path- 
1Abbreviations used in this paper: BCR, antigen receptor on B cells; GEF, 
guanine nucleotide exchange factors; GST, glutathione S-transferase; 
MAPK, mitogen-activated protein kinase; MBP, myelin basic protein; 
PLC, phospholipase C; PTK, protein tyrosine kinase; PTP, protein ty- 
rosine phosphatase. 
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PTK,  which  upon  TCR  ligation,  binds  via  its  SH2  do- 
mains  to  tyrosine-phosphorylated  TCR  and  manifests  a 
marked increase in catalytic activity thought to be responsi- 
ble for the phosphorylation and activation ofphospholipase 
C  (PLC)  yl  and  consequent  induction  of the  phospho- 
inositide  second-messenger pathway  (6-8).  Along  similar 
lines,  PTK-mediated  tyrosine  phosphorylation  of  TCP, 
subunits  also  results  in  recruitment  of Grb2  and  possibly 
other adaptor proteins, and these in turn serve to link the 
activated receptor to  guanine  nucleotide  exchange factors 
(GEFs), such as mSos, and thus to the activation of Ras and 
downstream mitogen-activated protein  (MAP)  kinases  (9, 
10). While TCR signaling capacity clearly reflects a host of 
other molecular interactions,  these  examples illustrate  the 
pivotal role for PTK-induced phosphorylation in the cou- 
pling of TCR engagement to a cell response. 
In contrast to the extensive data that is available concern- 
ing  PTK  involvement  in  TCR-driven  signaling  events, 
much  less  is  known  with  respect  to  the  contribution  of 
protein tyrosine phosphatases (PTPs) to the modulation of 
antigen  receptor  function.  On  the  basis  of considerable 
biochemical and genetic data, the single PTP that has been 
widely studied  in  relation  to  T  cell  signaling,  CD45,  ap- 
pears to  exert a primarily positive influence  on  the  TCR 
signaling capacity activity of this enzyme, apparently pro- 
moting  T  cell  development  and  activation  (11-13).  By 
contrast, the observed capacity of phosphatase inhibitors to 
enhance or even induce intracellular molecular events nor- 
mally elicited  by TClq.  ligation  (14)  suggests  that  at least 
some PTPs act in the downregulation of TCR.-evoked sig- 
naling  events.  Thus,  by providing the  biochemical means 
to counterbalance PTK effects and terminate receptor-ini- 
tiated signal  transmission,  PTPs potentially exert a key in- 
hibitory influence on T  cell signaling circuitry. 
Among  the  PTPs  identified  to  date,  the  cytosolic  en- 
zyme PTP1C  (SHP/HCP/SHPTP1)  represents a signaling 
effector that is particularly likely to be involved in the neg- 
ative regulation of TCR signaling capacity. This SH2 do- 
main-containing enzyme has,  for example, been shown to 
not only physically associate with the antigen receptor on B 
cells  (BCR), but to downregulate BCR-transduced signals 
evoking either the activation of mature B cells or the dele- 
tion/negative  selection  of autoreactive  precursor  B  cells 
(15,  16). PTP1C interactions with the CD22 and FcyRIIB 
receptors on B  cells also appear to culminate in the down- 
regulation  of BCP,.-triggered  activation  signals  (17,  18). 
These findings, together with recent data revealing a nega- 
tive regulatory influence of PTP1C  on the signaling func- 
tions of the erythropoietin and IL-3 receptors (19, 20), sug- 
gest that  PTP1C  may also  exert inhibitory  effects on  the 
signaling cascades elicited by TCR engagement. To address 
this possibility, we have examined TCR signaling capacity 
in thymocytes from motheaten  (me)  and viable motheaten 
(me  v) mice, animals in which PTP1C gene mutations result 
in  the  absence  of  catalytically  active  enzyme  (21,  22). 
While overt defects in thymocyte maturation were not de- 
tected in the mutant mice, the  induction  of proliferation, 
protein tyrosine phosphorylation, and MAP kinase activity 
after TCt/.  stimulation  was  markedly increased  in  me  and 
me  ~ thymocytes relative  to  cells  from congenic  wild-type 
mice. Among the phosphoproteins showing increased lev- 
els and duration  of tyrosine phosphorylation in the TCR- 
stimulated mutant cells were a number of species that asso- 
ciate with PTP1C  and/or  the Vav SH2  domain,  and  that 
are subject to PTP1C  tyrosine dephosphorylation in vitro. 
These latter proteins were found to include several compo- 
nents  of the  TCR  complex,  as  well  as  a  38-kD  species 
(pp38) that also associates strongly with the SH2 domain of 
the  Grb2  adaptor  protein  after  TCP,  ligation.  Together, 
these  findings  indicate  that  PTPIC  is  involved  in  the 
downregulation  of TCR-initiated signal  transduction path- 
ways, and suggest that PTP1C subserves this inhibitory role 
through  participation  in  a  nmltimeric  signaling  complex 
comprised of PTP1C, Vav, Grb2, and various phosphopro- 
teins  such  as  pp38  and  phosphorylated  TCR  subunits, 
which  appear to represent  PTP1C  substrates.  These find- 
ings therefore reveal the negative influence of PTP 1C on T 
cell signaling to be realized through PTP1C effects on both 
the  TCR  complex and more downstream signaling effec- 
tots that couple the TCP,. to Ras/MAP kinase activation. 
Materials and Methods 
Mice.  Mice  for  this  work  were  obtained  by  mating 
C3HeBFeJ  me/+  and  +/+  and  C57BL/6J  me'/+  and  +/+ 
breeding  pairs  derived  from  stock  maintained  at  the  Samuel 
Lunenfeld  Research  Institute,  Mount  Sinai Hospital  (Toronto, 
Ontario).  All mice used in this study were 2-3 wk old. 
Reagents.  Antibodies  used  for  these  studies include  FITC- 
conjugated  anti-CD4, PE-conjugated  anti-CD8, and biotin-con- 
jugated monoclonal hamster anti-mouse TCR (13 chain) antibod- 
ies  (Pharmigen,  San Diego,  CA);  a monoclonal rat anti-mouse 
CD3 antibody provided by Dr. G. Mills (M.D. Anderson Cancer 
Center,  Houston, TX); a monoclonal  rat anti-mouse CD5 anti- 
body  (Pharmigen);  rabbit  polyclonal  anti-Vav,  anti-Grb2,  and 
anti-EP,.K2(MAPK)  antibodies  (Santa Cruz  Laboratories,  Santa 
Cruz,  CA);  4G10  monoclonal  anti-phosphotyrosine  antibody 
(Upstate Biotechnology Inc., Lake Placid, NY); rabbit polyclonal 
PTPlC SH2 domain antibody produced in our lab (2l);  a rabbit 
polyclonal  anti-mouse  TCR-~  provided  by  Dr.  U  Samelson 
(NIH, Bethesda, MD); monoclonal anti-mouse CD3-~ provided 
by Dr. A. Singer (NIH, Bethesda, MD); and mouse  lgG (Sigma 
Chemical  Co.,  St.  Louis,  MO).  The  glutathione  S-transferase 
(GST) fusion proteins used in this study were derived by subclon- 
ing  the  following  cDNA  or  PCR-amp]ified  fragments  into 
pGEX2T:  the  full-length  murine  PTP1C  cl)NA  (PTP-1C/ 
GST),  a  full-length  murine  PTP1C  cDNA  containing  a 
Cys453-+Ser  mutation known to abrogate catalytic activity, pro- 
vided by Dr.  W.  Muller,  (McMaster University,  Hamilton,  On- 
tario) (C/SPTP1C/GST), and the Vav SH2 domain  (amino acids 
663-776)  alone  (Vav  SH2/GST)  and  the  Grb2  SH2  domain 
(amino acids 60--158) alone  (Grb2  SH2/GST),  provided by l)r. 
M.  P,.ozakis-Adcock  (Toronto,  Ontario)  (23). These  GST  ex- 
pression plasmids were transfected into Esdlerichia coil JM 101, and 
the fusion proteins  were purified from bacterial lysates after iso- 
propyl  13-D-thiogalactopyranoside induction.  OVA was obtained 
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PMA, and all chemicals  for immunoblotting/immunoprecipitation 
analyses were purchased from Sigma Chemical Co. 
Cells and Cell Lines.  Single-cell  suspensions  were  prepared 
from me,  me  v,  and wild-type congenic (+/+)  lymph nodes and 
thymus,  subjected to  erythrocyte lysis by 2-rain incubation  in 
0.8%  ammonium  chloride and the viability was  determined by 
staining in 0.4%  trypan blue (Sigma Chemical Co.). The murine 
EL4  thymoma  (TIB  39;  American  Type  Culture  Collection, 
ILockville, MD)  was  maintained at  37~  in  complete DMEM 
medium (GIBCO BRL, Gaithersburg, MD) containing 10% FCS 
(GIBCO BILL), 50 Izm 2-ME, 2 mm L-glutamine, and nonessen- 
tial amino acids. Cells were harvested in log growth phase. 
Fluorescence Staining  (FACS)  |  Single-cell  suspensions  pre- 
pared from me, me  ~, and wild-type congenic thymus were assessed 
for CD4, CD8, and TCIL expression by immunofluorescent anal- 
ysis,  as  described previously (24).  Briefly,  erythrocyte-depleted 
thymic single-cell suspensions (106 cells) were incubated for 30 
rain  at  4~  with  anti-CD4-FITC, anti-CD8-PE,  and biotiny- 
lated anti-TCR  antibodies.  Cells were  then  washed  and  incu- 
bated for a further 30 rain at 4~  with Tricolor Avidin (Caltag 
Laboratories, San Francisco, CA), and were then washed and re- 
suspended in staining solution. All samples were then examined 
by fluorescence cytometry using a FACScan  |  cell analyzer (Bec- 
ton Dickinson & Co., Mountain View, CA). 
Proliferation Assays.  Singe-cell suspensions of thymocytes har- 
vested from me,  me", and wild-type littermates were cultured in 
96-well flat-bottom microtiter plates (5  ￿  105  cells/100 I.zl per 
well)  in  (x-MEM  (GIBCO  BILL)  containing  10%  heat-inacti- 
vated FCS, 50 I~M 2-ME, and penicillin/streptomycin. For pro- 
liferation studies, cells were cultured directly with either 2.2 I~g 
Con A or 50 ng/ml PMA plus ionomycin (1 IxM), or in the pres- 
ence of 25 U/ml IL-2 (Sigma) in anti-CD3 antibody-coated cul- 
ture plates prepared by overnight incubation of the plates at 4~ 
with anti-CD3 antibody dissolved in 0.05 M  Tris-HC1, pH 9.2. 
Cells were cultured for 48 h at 37~  5% CO2, and pulsed with 
[3H]thymidine (1 I~Ci/well; Amersham International, Amersham, 
UK) 6 h before terminating incubation, and incorporated radio- 
activity was measured  using an automated 13  liquid scintillation 
counter.  For OVA proliferation assays, groups of me  v mice and 
normal littermates were treated by footpad injection of  50 or 100 p~g, 
respectively, OVA in CFA (GIBCO BILL), or CFA alone, as pre- 
viously described (24).  Animals were killed 7 d after immuniza- 
tion,  and  their popliteal, inguinal,  and  paraaortal lymph nodes 
were harvested and used to prepare single-cell suspensions. To re- 
duce  effects  of differences  between  me"  and  normal  accessory 
cells,  cells  obtained  from  two  OVA-primed animals  from  the 
same group  (i.e., me" or normal) were pooled and  mixed with 
equal numbers of cells obtained from the CFA-only-treated mice 
of the other group. Cells were then cultured (5 ￿  105 cells/well) 
for 72 h in a-MEM medium (as described above) in the presence 
or absence of varying amounts of OVA (ranging from 300 ng/ml 
to  3  mg/ml),  and  radiolabeled thymidine incorporation during 
the last 6 h of culture was evaluated as described above. 
Cell Stimulation and Lysis.  For analysis of  protein wrosine phos- 
phorylation  and  binding  studies  (see  below),  2-3  ￿  107  thy- 
mocytes or 3  ￿  107 EL4 cells were resuspended in, respectively, 
50 or 100 I~1 PBS, incubated for 30 rain at 4~  in the presence or 
absence of 2.5 Ixg biotin-conjugated anti-mouse TCIL antibody, 
and after the removal of unbound antibody, the cells were resus- 
pended in 40 txl PBS and incubated at 37~  for varying periods 
of time  with  100  I,  Lg/ml  avidin.  Alternatively, 3  ￿  107  thy- 
mocytes or EL4 cells were resuspended in 100  Izl PBS and then 
incubated for 2  rain at 37~  with pervanadate (1  mM Na3VOa 
plus 300 m/Vl H202).  After antibody or pervanadate stimulation, 
cells were pelleted by an 0.5-min centrifugation and then lysed by 
resuspension in 400 txl cold lysis buffer (150 mM NaC1, 50 
Tris-HC1, pH 8, 2 rnM EDTA, 50 m/Vl NaF, 1 mM PMSF, 1 mM 
sodium orthovanadate, and 0.05%  NAN3) containing either  1% 
NP-40 or 0.5% Triton X-100 as detergents. After a 15-rain incu- 
bation in lysis buffer, nuclei and unlysed cells were removed by 
centrifugation at 4~  for 10 min at 14,000 g, and 106 cell equiva- 
lents were then resuspended in SDS loading buffer and used as 
the source of protein lysates (see below). 
lmmunoprecipitation and Immunoblotting.  Lysates were precleared 
before immunoprecipitation by incubating  1 mg lysate protein 
with protein A-Sepharose (Pharmacia, Baie d'Urf~, PQ)  (40  txl 
lysate in 1-ml volume beads) for 1 h at 4~  and for an additional 
hour with 40 I~1 beads and 5 ILl rabbit preimmune serum. Lysates 
were then incubated for 3 h at 4~  with 5 Ix] specific antibody or 
rabbit preimmune serum and 25 p,1 packed protein A-Sepharose 
beads, and the immune complexes were then collected by cen- 
trifugation, washed four times in lysis buffer, and resuspended in 
SDS sample buffer. Alternatively, for reprecipitation studies, the 
immune  complexes  were  collected  by  centrifugation,  resus- 
pended in 200 I-tl lysis buffer with 0.5% SDS, and then boiled for 
5 rain. The resolubilized proteins were then further diluted by re- 
suspension in an additional 800  Ixl oflysis buffer and subjected to 
a second 3-h incubation at 4~  with  5  I.L1 antibody and 25  Ixl 
protein A-Sepharose beads followed by centrifugation, washing 
in lysis butter, and resuspension is SDS. The samples were boiled 
for 5 rain, electrophoresed through  10 or 15% SDS-polyacryla- 
mide,  transferred  to  nitrocellulose (Schleicher &  Schuller Inc., 
Keene, NH), and incubated at 4~  for at least 1 h in TBST solu- 
tion (150  mM NaC1,  10 mM Tris-HC1, pH 7.4,  0.05%  Tween 
20) plus 3% gelatin. Filters were then incubated for 2 h at room 
temperature with primary antibodies (1/5,000 dilution) in TBST 
followed by the addition of goat anti-mouse antiserum labeled 
with peroxidase (Amersham) and horseradish peroxidase-conju- 
gate  (BioRad Laboratories, Hercules,  CA).  Immune  complexes 
were  detected  using  an  enhanced  chemiluminescence  system 
(Amersham). 
In  Vitro Binding Assays.  Protein binding to various GST-SH2 
domain fusion proteins was examined by incubating total cell ly- 
sates  (1  rag)  for  1  h  at  4~  with  glutathione-Sepharose beads 
alone, and then for 3 h at 4~  with 5 txg glutathione-Sepharose- 
bound fusion protein. After four washes in lysis buffer, the pre- 
cipitated complexes were  resuspended in sample buffer, boiled, 
and analyzed by SDS-PAGE, and immunoblotted with selected 
antibodies as described above. 
Assay of Phosphatase Activity.  To measure PTP1C-induced de- 
phosphorylation  of  Vav-associated  proteins,  Vav  SH2-bound 
proteins prepared from 5  X  107 anti-TCiL antibody-stimulated 
wild-type thymocytes were washed three times in lysis buffer and 
twice  in  phosphatase  buffer  (62  m/vl  Hepes,  pH  7,  6.25  m/Vl 
EDTA), and then incubated at 37~  for varying periods of time 
in 25 ILl phosphatase buffer containing 12.5 mM DTT and either 
1 I~g or no (control) GST full-length PTP1C fusion protein. Re- 
actions were terminated by the addition of 6 I,  zl 5 ￿  SDS loading 
buffer, and the samples were then subjected to immunoblotting 
analysis with antiphosphotyrosine antibody. 
Assay of  MAP Kinase Activity.  Anti-ERK2  immunoprecipitates 
were prepared from 107 anti-TCR antibody- or PMA (25 nM)- 
stimulated wild-type thymocytes at varying intervals after cell stim- 
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resuspended in 25  Ixl reaction buffer (30 mM Tris-HC1, pH 8.0, 
20 mM Mg CI2, 2 mM MnC12 containing 5 Ixg myelin basic pro- 
tein (MBP; Upstate Biotechnology Inc.) and  10  IxCi [.y32_p] ATP 
(DuPont/New  England  Nuclear).  After a  15-min  incubation  at 
30~  reactions were terminated by the addition of 6  Ixl 5￿  load- 
ing  buffer,  and  the  samples  were  then  boiled,  electrophoresed 
through  15%  polyacrylamide gels,  and  transferred  to  nitrocellu- 
lose.  The phosphorylated  MBP  bands  were  either visualized by 
phosphoimaging  or stained  with  Pounceau  S,  excised from  the 
filters, and ~/32p  incorporation  was  evaluated by liquid scintilla- 
tion counting. 
Results 
TCR-elicited  Proliferation  Is  Enhanced  in  me  and  me'  T 
Cells.  Recent data implicating PTP1C  in the modulation 
of numerous  hemopoietic  cell growth  factor receptors  and 
indicating  the  substantial  expression  of this  phosphatase  in 
both  thymocytes  and  mature  peripheral  T  cells  have  re- 
vealed  a  likely role  for  PTPIC  in  the  regulation  of TCI< 
signaling (15,  19-21).  To begin elucidating PTP1C's  influ- 
ence on the ontogeny and activation ofT  cells, thymic cells 
isolated  from  PTPlC-deficient  motheaten  (me)  and  viable 
motheaten  (me ~)  mice  were  compared  with  normal  thy- 
mocytes  with  respect  to  the  surface  expression  of  CD4, 
CD8,  and TCP,,  as well as proliferative responses to TCR- 
dependent  mitogenic stimuli. As shown in Fig.  1,  results of 
three-color  flow  cytometry  revealed  no  differences  be- 
tween  me"  and  control  thymocytes  with  respect  to  the 
numbers  of  CD4,  CD8,  double-positive  cells,  and  CD4 
and  CD8  single-positive cells and  TCR  expression.  Thus, 
it appears  that  T  cell differentiation  can  proceed  nomlally 
in the absence ofPTP1C,  a conclusion consistent with pre- 
vious  data  linking  the  progressive  thymic  involution  that 
Figure  1.  Comparison  of T  cell maturation  and 
proliferative response to TCP,. stmmlation in moth- 
eaten vs. wild-type mice. (A) Flow cytometric anal- 
ysis ofthymocytes from C57BL/6J  +/+  (wild-type) 
and  C57BL/6J  me"/me  v  (Me  v)  mice.  Thymocytes 
isolated from 3-wk-old wild-type and mutant  mice 
were stained with FITC-conjugated anti-Cl)4, PE- 
conjugated anti-CD8,  and biotinylated anti-TCIX-IB 
antibodies  followed  by Tricolor-steptavidin.  After 
staining,  cells were  analyzed  by  triple-color flow 
cytometry  for the expression of CD4 vs. C1)8  (le/? 
panels) and for levels of TCR expression as shown 
by the single parameter histograms on the right. For 
the two-color plots, the numbers in the upper right 
corners  represent  the percentage  of cells found  in 
each  quadrant.  (B)  Proliferative  responses  of 
C57BL/6J  me'Tree"  (Me") and  normal  littermates 
(C57BL litt) and C3 HeBFeJ me/me (Me) and nor- 
mal littermates (C3H litt) to antigen receptor stmm- 
lation.  Thymocytes  (5  ￿  1()  s cells/well)  were ob- 
tained from me,  me  v, and congenic  littennates,  and 
were cultured  for 48 h with 2.2 Ixg Con A in un- 
treated microtiter plates or for 48 h in the presence 
of 25 U/ml IL-2 in nficrotitre plates precoated with 
anti-C1)3  antibody.  Proliferation  was evaluated by 
measuring  [-~H]thymidine incorporation  during  the 
last 6 h culture. Data are expressed as cpm, and the 
values represent  lneans  (--- SEM)  of quadruplicate 
cultures. (C) In vitro OVA-specific proliferative re- 
sponses of C57 BL/6J me'line" (Me  ~) and congenic 
normal litter mate (C57BL litt) T cells after in vivo 
priming  with OVA.  Lymph  nodes  were harvested 
from  nle  ~ and  normal  littermate  lymph  nodes  at 
10 d after immunization  with 50--1(10 btg OVA, as 
described in Materials and  Methods.  OVA-primed 
cells from  two me' mice or two congenic  controls 
were pooled and  mixed with  equivalent  numbers 
of lymph node cells derived  from adjnvant-pmued 
normal  or m~  ~' mice,  respectively.  Cells were  cul- 
tured for 72 h at 5 ￿  10  s cells/well in the presence 
of varying amounts  of OVA, and proliferation  was 
evaluated  after  a  6-h  pulse  with  pHlthymidine. 
The values represent  means  (+_  SEM)  of triplicate 
cultures. 
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TCR-induced  protein tyrosine 
phosphorylation in viable moth- 
eaten vs.  wild-type thymocytes. 
(A)  Cell lysates were prepared 
from  10  {'  unstinmlated (O')  or 
anti-TCR  antibody (2.5 ~tg)/ 
avidin-treated  C57BL/6J meV/ 
me"  (Me") or  C57BL/6J +/+ 
wild-type  (Vv"/) thymocytes at 
the indicated times after stinmla- 
tion. After fractionation by SDS- 
PAGE, the phosphotryosine-con- 
raining proteins  were detected 
by  immunoblotting  .with  an- 
tiphospbotyrosine antibody (atM- 
pTyr). The arrows indicate posi- 
tions  of  two  protein species 
(~38  and  26  kD,  respectively) 
for which tyrosine phosphoryla- 
tion appears enhanced in the me  v 
thymocytes. Mobilities of mo- 
lecular mass standards are shown 
on the left. (B) The filter shown 
in A was stripped and reprobed 
with anti-CD3-{ antibody. 
occurs in  me and  me" mice primarily  to the pathogenic  ef- 
fects of infiltrating myelomonocytic ceils rather than to in- 
trinsic  T  cell defects per se  (25).  In contrast to differentia- 
tion,  however,  thymocyte proliferative  responses  to  TCR 
stimulation,  as  evaluated  by  [3H]thymidine  incorporation, 
differed markedly between the mutant mice and wild-type 
controls.  Me"  thymocytes,  for  example,  in  which  PTP1C 
catalytic activity is present, but at very low levels, exhibited 
maximal  proliferative  responses  to  both  Con  A  and  anti- 
CD3 antibody/IL-2 stimulation  that were much greater in 
magnitude  than  those  observed in similarly treated  thymic 
cells  from normal littermates  (Fig.  1 /3). Hyperresponsive- 
ness  to  TCR  stimulation  was  even  more  pronounced  in 
thymocytes from me mice, which lack any PTP1C activity 
(Fig.  1 B), and was also revealed by the apparent capacity of 
both  me  and  me  ~ thymic  cells  to  proliferate  in  response  to 
normally submitogenic  concentrations  of Con A  (data  not 
shown).  By  contrast,  both  the  magnitude  and  kinetics  of 
the  proliferative  responses  to  several  TCR-independent 
stimuli,  including  IL-2  alone  and  PMA/ionomycin,  were 
essentially  the  same  in  the  mutant  and  wild-type  thymo- 
cytes (data not shown). Together, these data reveal a defect 
in the transduction of TCR-evoked proliferation signals in 
me and me" thymic cells  and suggest that PTPIC  effects on 
TCR-driven  mitogenesis  may  be  similar  to  those  previ- 
ously described in relation to the BCR  (15). 
To  determine  whether  PTP1C  also  influences  antigen 
receptor function in mature  T  cells,  lymphocytes obtained 
from lymph nodes of OVA-primed me". and wild-type con- 
genic  mice  were  compared  with  respect  to  their  in  vitro 
proliferative  responses  to  OVA  stimulation.  Since  these 
studies  were  performed  using  crude  lymph  node  suspen- 
sions, the potential influence of contaminating antigen-pre- 
senting  nonlymphoid  cells  was  addressed  by culturing  the 
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OVA-primed me  v cells with CFA-primed cells from normal 
congenic mice in a  1:1  ratio. As shown in Fig.  1 C, the re- 
sults  of this  analysis  revealed  the  T  cell  proliferative  re- 
sponses to varying doses of antigen stimulation  to be again 
substantially increased in me  v compared to control lympho- 
cytes. While this result might reflect the capacity of a more 
permissive  microenvironment  to increase  the  sensitivity  of 
the  me" cells  to in vivo priming,  this  possibility seems  un- 
likely in view of considerable data imbuing the me and me  v 
mutations  with  a  predominantly  inhibitory  effect on lym- 
phoid cell growth and function (26, 27). Instead, these data 
are  more  consistent  with  a  role  for PTP1C  in  regulating 
TCR-elicited  mitogenesis in both mature  T  cells  and thy- 
mocytes  and  suggest  that  the  effects  of PTPIC  on  TCR 
signaling are largely inhibitory. 
TCR  Complex  Components  Associate  with  PTP1C  in  Rest- 
ing  and Activated  Thgmocytes,  and Are  Hyperphosphorylated  in 
the  Context  of PTPIC  Deficiency.  To elucidate  the molec- 
ular  basis  for  PTP1C  influence  on  TCR-initiated  T  cell 
proliferation,  me" and normal thymocytes were next  com- 
pared  with  respect  to  their  profiles  of protein  tyrosine 
phosphorylation  after  TCR  ligation.  As  demonstrated  by 
antiphosphotyrosine immunoblotting analysis, anti-TCR anti- 
body treatment resulted in the rapid tyrosine phosphoryla- 
tion of a number of protein species in both the normal and 
me" cells  (Fig.  2 A).  However, in contrast to the wild-type 
cells,  in which  tyrosine phosphorylation levels  peaked --~1 
rain after TCR  ligation,  me  v thymocytes showed more sus- 
tained  increases  in  tyrosine  phosphorylation,  with  at  least 
four  phosphoproteins  (75-,  70-,  38-,  and  26-kD  species) 
remaining relatively hyperphosphorylated at 5 and even 30 
min after cell stimulation.  Among these latter proteins,  the 
phosphorylation  of the  75-  and  38-kD  species  also  ap- 
peared relatively increased in unstimulated  me" compared to Figure  4.  Association  of PTPIC with CD5  in resting and activated 
thymocytes.  Lysates prepared  front  3  ￿  10  7 unstimulated  (-)  or anti- 
TCR antibody/avidin-stimulated  (+) wild-type thymocytes were immu- 
noprecipitated  with anti-PTP1C or anti-CD5 antibodies or with  rabbit 
preimmune serum  (C), resolved over SDS-PAGE,  and immunoblotted 
with antiphosphotyrosine  (A) or anti-PTPIC (/3) antibodies. The posi- 
tions of CD5 and PTP1C are indicated on the right, and the positions of 
molecular mass standards are shown on the left. 
Figure 3.  Association  of PTP1C with  the resting and activated TCR 
complex.  (A) Lysate proteins prepared from 3  ￿  10  v C3HeBFeJ  me~me 
(Me)  or  C3HeBFeJ+/+  (WT)  thymocytes  were  nnmunoprecipitated 
with  either  anti-TCR-~  (left  and  nliddle  panels)  or  anti-TCR-{  (riqht 
panel)  antibodies, resolved on SDS-PAGE, and subjected to immunoblot- 
ting with antipbosphotyrosine (left and right panels)  or anti-CD3-e (middle 
panel)  antibodies. Arrows indicate the  positions of two  phosphoproteins 
showing relatively increased phosphorylation in the me compared to wild- 
type cells. (/3) At the indicated times after stimulation with anti-TCP,.-[B 
antibody/avidin,  lysates prepared from 3 ￿  10  v EL4 cells or 3 X 10  7 wild- 
type thymocytes (last  tu,o lanes on  the  filr right)  were inmmnoprecipitated 
with  anti-TCR  (Ip:TCR)  or  anti-CD3-e  (lp:c~-C1)3e) antibodies,  or 
with an excess of purified nmrine IgG (Ip:mlgG) and the lysate (Lys) or 
immunoprecipitated  proteins then resolved by SDS-PAGE and subjected 
to innnunoblotting  with anti-PTP1C antibody. An arrow on the left in- 
dicates the position of PTP1C. The positions of molecular mass markers 
are also shown on the left. 
normal thymocytes  (Fig.  2  A).  These  data,  together  with 
our detection of similar changes in tyrosine dephosphory- 
lation kinetics in TCP..-stimulated me  thymocytes (data not 
shown), suggest that PTPlC  effects on TCR-induced  pro- 
liferation are realized, at least in part, at the earliest stages of 
signal  transduction,  and  might  include modulation of the 
TCIL  complex  tyrosine  phosphorylation  status.  To  begin 
addressing this  latter possibility,  the  immunoblot of wild- 
type  and  me"  thymocyte  proteins  shown  in  Fig.  2  A  was 
reprobed  with  anti-CD3-e  antibody, and the  comigration 
of this  26-kD  TCIL  subunit with  one  of the  proteins  ap- 
pearing hyperphosphorylated  in TCR-stimulated  me"  thy- 
mocytes was thereby demonstrated (Fig. 2  B). Based on this 
observation, we next assessed the tyrosine phosphorylation 
status  of TCR  complexes  immunoprecipitated from  0.5% 
NP-40  lysates  of unstimulated  wild-type  and  me  thymo- 
cytes. As indicated by the antiphosphotyrosine immunoblot 
shown  in  Fig.  3  A  (left  panel),  augmented  tyrosine  phos- 
phorylation  of several  proteins  in  the  size  range  of CD3 
subunits (26 and 19 kD)  was again detected  in the  me  cells 
(Fig.  3  A), and the identity of these latter phosphoproteins 
as  CD3-e  and TC1L-~,  respectively, was  established by re- 
probing  of the  latter  filter  with  anti-CD3-e  antibody,  as 
well as by the demonstration of enhanced phosphorylation 
of TCR-~  chains immunoprecipitated from me thymocytes 
(Fig. 3 A). Together, these data provide strong evidence for 
the  hyperphosphorylation  of  the  TCIL  components  m 
PTPlC-deficient  thymocytes,  and  thus  identify  the  TCR 
subunits as potential substrates for PTP1C. 
In view of'these observations, the possibility that PTP1C 
physically associates  with  the  TCR.  was  also  explored  by 
anti-PTPlC  immunoblotting analysis  of TCR  immuno- 
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EL4 thymoma cells. As shown in Fig. 3 B, PTPIC was eas- 
ily detectable in the  TCR  precipitates derived from both 
resting and stimulated cells, the amount of TCR-associated 
PTP1C  appearing  essentially unchanged by  cell  stimula- 
tion. Similarly, PTPIC was coprecipitated with the TCR 
component CD3-e, from both resting and stimulated thy- 
mocytes (Fig. 3  B),  and phosphorylated species in the size 
range of TCR subunits were also detected by antiphospho- 
tyrosine immunoblotting  analysis ofanti-PTPlC immuno- 
precipitates derived from wild-type thymocyte lysates (data 
not shown). Association of the TC1K with PTPtC was also 
studied by examining interactions of this phosphatase with 
CD5, a membrane glycoprotein that associates with TCR~ 
and undergoes rapid  tyrosine phosphorylation after  TCR 
ligation consequent to  interactions with  src-related PTKs 
(28-30). As shown in Fig. 4, the results of anti phosphoty- 
rosine and anti-PTP1C immunoblotting analysis of CD5 
immunoprecipitates from resting and anti-TCR-stimulated 
thymocytes confirmed that CD5 is rapidly phosphorylated 
after TCR  ligation, and also demonstrated the capacity of 
PTP1C to associate with CD5 in activated thymocytes. In 
view of the recognized binding of CD5 molecules with the 
TCR  complex, these observations provide further evidence 
for the physical association of PTPIC with the TCR. 
Identification  of  Vav-  and  Grb2-associated  Phosphoproteins  as 
Substrates for PTP1C  in Activated  Thymocytes.  In addition to 
interactions with various cell-surface receptors, PTP1C has 
recently been  shown  to  asssociate  with  both  the  95-kD 
product  of the  Vav  protooncogene  and  the  Grb2/mSos 
complex in activated hemopoietic cells  (31).  While the bio- 
chemical function of Vav is uncertain, Vav has been found 
Figure 5.  Phosphotyrosine  protein binding to Vav is enhanced in PTP1C-deficient compared to normal activated thymocytes. (A) Lysates were pre- 
pared at the indicated times after Con A stimulation  of 3 ￿  107 C3HeBFeJ me~me (Me) and congenic wild-type (W'/) thymocytes. Lysate proteins were 
resolved by SDS-PAGE, transferred to nitrocellulose,  and immunoblotted with antiphosphotyrosine  antibody. Arrows indicate the positions  of Vav and 
two species showing increased tyrosine phosphorylation  in the me compared to wild-type samples at 5 rain after cell stinmlation.  (B) Lysates prepared at 
the indicated times after anti-TCR antibody/avidin stimulation  of 3 ￿  107 C57BL/6J meV/me  v (Me  v) and congenic, wild-type (W'/) thymocytes  were 
subjected to SDS-PAGE  and antiphosphotyrosine  immunoblotting  analysis.  Arrows indicate the positions  of Vav and a 38-kD species showing increased 
phosphorylation  in the me  v samples at 1 rain after cell stimulation.  (C) Lysates prepared from 3 ￿  10  v C57BL/6J meVme  v (Me  v) and congenic wild-type 
(WT) thymocytes  at the indicated  times after anti-TCR antibody/avidin  treatment were incubated for 1 h with 5 ptg GST-Vav SH2 domain fusion  pro- 
teins adsorbed to glutathione-Sepharose,  and the bound proteins then fractionated  by SDS-PAGE, transferred  to nitrocellulose  and subjected to immuno- 
blotting with antiphosphotyrosine  antibody. Arrows indicate  the positions  of two phosphoproteins (~38 and 26 kD) that are more pronounced in the me  v 
relative to wild-type cells at 5 and 20 rain after TCR stimulation.  Precipitation  with GST bound to glutathione-Sepharose  (.far right lane) was used as a 
negative control. For all panels, the positions  of molecular mass markers are shown on the left side. In A and B, loading of equivalent  amounts of lysate 
proteins was confirmed  by reblotting with anti-Vav  antibody (data not shown). 
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has been identified as an essential participant in the cellular 
response to  TC1L stimulation  by results showing that  ge- 
netic  ablation  of Vav expression  severely impedes  TCR- 
evoked signal  transduction  and  thymocyte  differentiation 
(33,  34).  Similarly, the Grb2 adaptor appears to be of con- 
siderable importance to T  cell signaling by virtue of its role 
in coupling TCR-associated PTKs to the 1Las GEF, mSos, 
and thus to the activation of Ras (35,  36). Accordingly, the 
capacity of PTP1C  to associate with Vav and  Grb2/mSos 
suggests that PTP1C influence on TCtL signal transduction 
is also realized through its effects on downstream biochem- 
ical  events  that  are  required  for activation of the  tkas  re- 
sponse pathway.  To address  this  issue,  the  tyrosine phos- 
phorylation  of Vav and  the  association  of Vav and  Grb2 
with  other phosphotyrosine-containing proteins were ex- 
amined  in  resting  and  antigen  receptor-stimulated  thy- 
mocytes of me,  me  ~,  and wild-type mice For these studies, 
lysates from Con A  or anti-TCR antibody-treated mutant 
and control thymocytes were precipitated with anti-Vav or 
anti-Grb2  antibodies  and  glutathione-Sepharose-bound 
GST-Vav SH2  domain  or  GST-Vav  Grb2  SH2  domain 
fusion proteins, and the precipitated complexes were then 
subjected to  antiphosphotyrosine  immunoblotting.  As de- 
picted in Figs. 5, A and B, the analysis  ofVav immunopre- 
cipitates  in  these  cells  showed  that  Vav  is  constitutively 
phosphorylated in both wild-type and mutant thymocytes, 
but, as has been previously reported, tyrosine phosphoryla- 
tion  of this  protein  increased  rapidly  after  TCR  ligation 
(23).  This  analysis  also  revealed  the  presence  of several 
other phosphoproteins of'~70-75 kD and of 38 kD, in the 
Vav immunoprecipitates from stimulated mutant and wild- 
type cells. However, in contrast to Vav, for which the levels 
and kinetics of tyrosine phosphorylation were comparable 
in  the  wild-type  and  mutant  thymocytes,  tyrosine  phos- 
phorylation of these latter Vav-associated phosphoproteins 
appeared, at least within the first 5 rain of receptor stimula- 
tion,  to be considerably more pronounced in  me and to  a 
lesser  extent,  me"  thymocytes, relative  to  control  thymo- 
cytes.  This result  cannot be ascribed to  differences in  the 
amount  of Vav protein  among the  various samples,  since 
reprobing  of these  immunoblots  revealed  the  amount  of 
Vav to be equivalent in all lanes (data not shown). Since in- 
creased and sustained  tyrosine phosphorylation of proteins 
in  this  same  approximate size  range  was  also  detected  in 
whole-cell lysates from anti-TC1K-stimulated  me"  thymo- 
cytes  (Fig.  2),  it appears likely that  PTP1C  modulates the 
tyrosine phosphorylation of these proteins and may thereby 
influence  their  association  with  Vav  after  TC1L  ligation. 
Conversely, while our previous data have revealed the as- 
sociation  of Vav  with  both  PTP1C  protein  and  phos- 
phatase  activity  (31),  the  current  findings  suggest  that 
PTP1C  does  not  modulate  TCR-induced  Vav  tyrosine 
phosphorylation,  and  thus  imply  that  any  effects PTP1C 
exerts on the function of Vav in relation to T  cell signal re- 
lay reflect the actions of this phosphatase on Vav-associated 
proteins and/or signaling effectors proximal to Vav activafon. 
Previous results from our group and others have demon- 
strated  the  capacity of both PTP1C  and  Vav  to  associate 
with the Grb2 adaptor protein, a molecule which by virtue 
of its SH2 and SH3 domains binds to both tyrosine phos- 
phorylated receptor or receptor-associated adaptor proteins 
and to the mSos GEF, respectively, and thereby plays a key 
role in linking receptor to Ras activation in many cell types 
(36,  37). In view of these data, as well as the apparent influ- 
ence  of PTP1C  on  phosphoprotein  binding  to  Vav  after 
TCR  ligation,  the  possibility  that  PTP1C  modulation  of 
receptor-triggered activation reflects its effects on tyrosine- 
phosphorylated  signaling  molecules  normally recruited  to 
the Vav and  Grb2  SH2  domains  was next examined.  To 
this end, lysates from resting and stimulated control and me" 
thymocytes were  incubated  with  GST-Vav SH2  domain 
and GST-Grb2 SH2 domain fusion proteins, and the SH2 
domain-bound  phosphoproteins  were  then  visualized  by 
antiphosphotyrosine immunoblotting analysis. As illustrated 
in Fig.  5 C, the results of this analysis revealed stinmlated T 
cell lysates to contain multiple Vav SH2 domain-associated 
tyrosine phosphoproteins which, based on apparent molec- 
ular  mass, include  some of the  same phosphorylated pro- 
teins (70-75 and 38 kD) coprecipitated with Vav from acti- 
vated T  cells (Fig.  5, A  and B), as well as additional species 
of 120 and 26 kD, respectively. These findings are consis- 
tent with previous data that indicate association of the Vav 
SH2  domain  with  70-kD  and  74-kD  phosphoproteins  in 
activated Jurkat cells  (38).  Moreover, as the tyrosine phos- 
phorylation  of the  Vav  SH2-associated  phosphoprotems 
detected  in  the  stinmlated  thymocytes  studied  here  was 
again more pronounced and sustained in  me" compared to 
control  cells,  these  results  provide  further  evidence  that 
PTP1C  effects on  T  cell  signal  transduction  involve  the 
modulation  of  Vav  SH2  domain-mediated  interactions 
with  phosphorylated  signaling  effectors,  presumably  be- 
cause  of PTP1C's capacity to  tyrosine dephosphorylate at 
least some of these phosphoproteins. 
Induction  of tyrosine  phosphoprotein  binding  to  the 
Grb2  adaptor  SH2  domain  was  also  evaluated  in  anti- 
TCR-treated me" and wild-type thymocytes, and as shown 
in Fig.  6 A, this analysis revealed a prominent 38-kD phos- 
phoprotein  (herein  designated  as  pp38)  to  be  associated 
with  Grb2 SH2 in both the  me" and wild-type stinmlated 
cells:  again,  the level and duration  of pp38 tyrosine phos- 
phorylation were augmented in  me" relative to the control 
thymocytes.  Similarly,  a  38-kD  phosphoprotein  was  the 
predominant  molecular  species  coprecipitated  with  Grb2 
from wild-type thymocytes after TCR ligation (Fig.  6  B). 
Since  this  species  was  found  to  comigrate  with  the  Vav 
SH2 domain-associated 38-kD phosphoprotein and was no 
longer detectable in Grb2 SH2 domain precipitates derived 
from activated thymocyte lysates pretreated with an excess 
of GST-Vav SH2 domain fusion protein (data not shown), 
it appears likely that this 38-kD Grb2 SH2-binding phos- 
phoprotein represents the same protein associated with the 
Vav  SH2  domain  in  anti-TClk-stimulated  thymocytes. 
While  the  identity  of pp38  was  not  established  here,  a 
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is increased in viable motheaten relative to normal thymocytes. (A) Ly- 
sates prepared from 3 ￿  10  v C57BL/rJ meV/me v (Me  v) and congenic wild- 
type (I8/7) thymocytes at the indicated times after stimulation with anti- 
TCR antibody/avidin were incubated for 1 h with 5 p.g GST-Grb2 SH2 
domain fusion protein absorbed to glutathione-Sepharose. The precipi- 
tated phosphoproteins were then  resolved by fractionation over SDS- 
PAGE and visualized by antiphosphotyrosine immunoblotting. Positions 
of molecular mass standards are shown on the left. (B)  Lysate proteins 
from 3  ￿  107 anti-TCR antibody/avidin--stimulated wild-type thymo- 
cytes were immunoprecipitated with anti-Grb2 antibody, resolved over 
SDS-PAGE, and  immunoblotted  with  antiphosphotyrosine antibody. 
The arrow on the right indicates the position of  p38. 
phosphoprotein  of a  similar  molecular  mass  (i.e.,  36-38 
kD)  has  been  shown  to  interact  with  not  only Grb2,  but 
also PLC-~/1 and phosphatidylinositol-3 kinase in activated 
T  cells  (39-41).  Based on these data, pp38 has been impli- 
cated in the coupling of TCR-associated PTKs to signaling 
effectors such as the Grb2/mSos complex, and accordingly to 
Ras activation (40), a hypothesis consistent with recent data 
linking the uncoupling ofpp38 from the Grb2/mSos com- 
plex to the attenuation  of the Ras activation response in T 
cells (42). While it is currently unclear whether the 38-kD 
species  identified  here  represents  Lnk,  a  recently  isolated 
SH2 domain-containing protein with biochemical proper- 
ties similar to those  of pp38  (43), the  current findings that 
reveal  TCR  ligation  to  induce  pp38  association  with  not 
only the Grb2 SH2 domain, but also with the SH2 domain 
ofVav, a putative GDP/GTP  exchanger for Ras,  are con- 
sistent with the contended role for pp38 in the biochemical 
cascade linking TCR  ligation to Ras nucleotide exchange. 
By extension,  these data imply that PTP1C, by virtue of its 
effects on pp38 associations with both Vav and Grb2, plays 
a  pivotal  role  in  regulating  receptor-initiated  signaling 
events immediately upstream to Ras activation. 
The enhanced tyrosine phosphorylation of various Vav- 
and Grb2-associated phosphoproteins  detected  in PTP1C- 
Figure  7.  In vitro tyrosine dephosphorylation of Vav SH2-associated 
phosphoproteins by GST-PTPIC fusion protein. Lysates  prepared from 
5 ￿  107 anti-TCR  antibody/avidin-treated wild-type thymocytes were 
incubated for 1 h with 5 ~g Vav SH2 domain fusion protein adsorbed to 
glutathione-Sepharose, and the complexes  were then retrieved and incu- 
bated for the indicated times in phosphatase buffer alone (ctrl)  or buffer 
containing 1 la.g GST-PTP1C fusion protein. In vitro dephosphorylation 
was assessed by immunoblotting with anti-phosphotyrosine  antibody. Ar- 
rows indicate positions of three prominent Vav SH2 domain-associated 
phosphoproteins of  N70, 38, and 26 kD, respectively. 
deficient  thymocytes  after  TCR  ligation  suggested  that 
these latter proteins  represent  targets for PTP1C-mediated 
dephosphorylation.  To  investigate  this  possibility,  the  ca- 
pacity of PTP1C  to  tyrosine  dephosphorylate  Vav-associ- 
ated  phosphoproteins  was  examined  by incubating  GST- 
Vav SH2  domain precipitates  from activated  T  cell lysates 
with  recombinant PTP1C.  As shown  in  Fig.  7,  antiphos- 
photyrosine  immunoblotting  analyses  of  these  PTP1C- 
treated precipitates revealed the progressive dephosphoryla- 
tion of pp38,  the latter being undetectable  at 30 min after 
enzyme addition,  as well as dephosphorylation of a second 
species  of r  kD,  possibly representing  a Vav-associated 
TCR  component.  These  results  do  not  appear  to  reflect 
the random targeting of all tyrosine phosphorylated species 
in the samples by the recombinant protein, since the phos- 
phorylation state of a third Vav-binding phosphoprotein of 
70 kD appeared to be unaffected by PTP1C, at least during 
the  30-min interval  of this  analysis.  To further address the 
possibility that the 38- and 26-kD phosphoproteins  repre- 
sent  PTPIC  substrates,  however,  lysates  prepared  from 
wild-type thymocytes treated  with pervanadate,  a  tyrosine 
phosphatase  inhibitor  known  to  induce  intracellular 
changes that mimick those observed during TCR-triggered 
T  cell activation (14), were precipitated  with  either  GST- 
PTP1C  or the  catalytically inert  GST-C/S  PTP1C fusion 
proteins,  and  the  effect  of abrogating  PTPIC  activity  on 
the enzyme's association with phosphoproteins in activated 
thymocytes was  then  assessed  by antiphosphotyrosine  im- 
munoblotting.  The  results  of this  analysis  revealed  both 
versions  of the  PTPlC-GST  fusion proteins  to coprecipi- 
rate a number of phosphoproteins  from stimulated  T  cells, 
but  as  shown  in  Fig.  8,  many  of these  species  appeared 
847  Pani et al. Figure 8.  Association  of PTPIC and the Vav SH2 domain with phos- 
phorylated TCR components and p38. (A) Triton (0.5%) lysates prepared 
from 3 X 107 unstimulated (-) or pervanadate-treated (+) wild-type thy- 
mocytes were precipitated with the indicated antibody (anti-TCR) or fu- 
sion protein (GST-C/S PTP1C, GST-PTP1C, or GST). The complexes 
were then fractionated over SDS-PAGE, transferred to nitrocellulose, and 
subjected to antiphosphotyrosine immunoblotting analysis. Arrows indi- 
cate the positions ofcomigrating tyrosine phosphory/ated species detected 
in the GST-C/S  PTPlC, Vav SH2, and anti-TCP, precipitates. (B) For 
identification of the lower molecular mass phosphoproteins  (19-26 kD) 
observed in A, 0.5% Triton lysates prepared from 3 ￿  1(17 pervanadate- 
treated thymocytes were precipitated with either anti-TCP, antibodies or 
GST-Vav SH2 domain fusion proteins and aliquots of  the GST-Vav SH2 
domain complexes were then reprecipitated with anti-TCP,-{ antibody, 
anti-CD3-e  antibody, or  lnurine lgG, as  described in  Materials and 
Methods. The  reprecipitated proteins were resolved over SI)S-PAGE, 
transferred to mtrocellulose, and immunoblotted with antiphosphotyro- 
sine antibody. Arrows indicate the positions of the TCR-~  (plg)  and 
C1)3-~ (p26) chains. In both panels, positions of molecular inass standards 
are shown on the left. 
markedly  more  phosphorylated  in  the  lysates  precipitated 
with  the  catalytically  inactive  instead  of  the  wild-type 
PTP1C  fusion  protein.  Among  these  latter  phosphopro- 
teins,  we  detected  species  of 38,  26,  21,  and  19  kD  that 
comigrated  with  phosphoproteins  precipitated  from  acti- 
vated  thymocyte  lysates  by  anti-TCR  antibodies  and/or 
GST-Vav  SH2  domain  fusion proteins,  and  that  are  thus 
likely to represent  the same molecular species found to be 
aberrantly  phosphorylated  in  TCP-  and  Vav immunopre- 
cipitates from activated me and me  ~ thymocytes. This conten- 
tion  is  supported  by the  results  of reprecipitation  analyses 
that were used to determine whether any of the  19-26-kD 
species  precipitated  from  the  activated  cells  by  GST-Vav 
SH2 domain fusion proteins represented  TCR  components. 
As shown in  Fig.  8  B,  the  results  of this  latter  analysis  re- 
vealed  the  presence  of both  TC1L-~  and  CD3-e  in  Vav 
SH2 domain precipitates  from activated thymocytes. Thus, 
these data confirm the association of both Vav and PTPI C 
with  TCR  components in activated T  cells  and,  based on 
the reduction in phosphorylation of the  19-26- and 38-kD 
proteins when precipitated with active vs. catalytically inert 
GST-PTP1C  fusion  proteins,  these  findings  support  the 
contention  that pp38  and the phosphorylated  components 
of  the  TCR  complex  represent  substrates  for  PTP1C. 
While  these observations might also be explained by indi- 
rect effects of PTP1C on the phosphorylation of these lat- 
ter  proteins,  for example,  through  the  modulation  of one 
or more PTK activities, the capacity of PTP1C to associate 
with and tyrosine dephosphorylate in vitro at least some of 
these  species  (Fig.  7)  strongly suggests  that these phospho- 
proteins  represent  physiologic  substrates  for  PTP1C.  Ac- 
cordingly,  the  negative  regulatory  effects  of PTPIC  on 
TCP,. signaling capacity appear to be  realized  through  the 
dephosphorylation  of activated  TCR  components,  as well 
as the downstream signaling effectors that are normally in- 
volved in the induction of Ras activation. 
TCR-evoked MAP Kinase Aaivation  Is Prolonged in PTP1C- 
deficient  Tkymocytes.  In  view  of  these  data  implicating 
PTP1C  in  the  regulation  of the  signaling cascades linking 
TCR  stimulation to Ras activation,  the influence of PTP1C 
on  the  Ras  regulatory  pathway  was  further  examined  by 
evaluating the  effects of PTP1C  deficiency on TCR-pro- 
yoked activation  of MAP kinase  (MAPK).  MAPKs belong 
to a group of serine/threonine  kinases shown in many cell 
systems  to  engage  in  sequential  phosphorytation  cascades 
that direct P,  as activation signals to the nucleus  (44).  With 
specific respect to antigen receptor signaling in T  cells,  the 
induction of MAPK activity appears tightly coupled to Ras 
activation, TCR-elicited increases in MAPK activity being 
essentially abrogated by the loss of Ras function and the ge- 
netic  disruption  of either R.as  or MAPK function yielding 
very similar defects in thymocyte development in vivo (45, 
46). Accordingly, to assess the influence of PTP1C oi1 sig- 
naling events downstream to TCR-induced IZas activation, 
antibodies  reactive  with  the  ERK2  MAPK  were  used  to 
immunoprecipitate  MAPK  from  resting  and  anti-TCR. 
stimulated  me" and wild-type thymocytes, and the immune 
complexes  were  then  evaluated  for  their  ability  to  phos- 
phorylate  MBP.  As  shown  in  Fig.  9  A,  the  results  of this 
analysis  indicate  the  rapid  induction  of increased  MAPK 
activity in both the  me" and normal cells  after TCR  cross- 
linking. However, while the absence of PTP1C activity did 
not appear to influence basal levels of  MAPK activity or the 
peak kinase activity observed immediately after receptor li- 
gation (Fig. 9, A and B), the increases in MAPK activity in- 
duced by TCP, stimulation were consistently prolonged in 
the me" relative to the control cells.  Thus, while MAPK ac- 
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Kinetics of MAPK activation are altered in PTPlC-deficient 
motheaten thymocytes. Lysates were prepared from 3  x  10  7  anti-TCR 
antibody/avidin- or PMA-stimulated C57BL/6J meV/me v (Me") and con- 
genic wild-type (WT) thymocytes at the indicated times after cell stimula- 
tion. Lysate proteins were then immunoprecipitated with anti-ERK2 an- 
tibody, and the immune  complexes then  evaluated for their ability to 
phosphorylate MBP after SDS-PAGE fractionation and autoradiography. 
(A) Representative example showing the kinetics of MAPK activation in 
mev-derived  (wen  squares)  and  WT-derived  (closed  circles)  thymocytes 
within the first 20 min after TCR stimulation. The incorporation of 32P 
by the MBP substrate was quantitated by densitometric analysis  (Molecu- 
lar Dynamics Phosphorlmager), and the values are expressed as the fold 
increase in MAPK activity (i.e., MBP phosphorylating activity in stimu- 
lated relative to unstimulated cells). (/3) Comparison of me'  vs. wild-type 
thymocytes with respect to levels of MAPK activity at varying times al~er 
TCR ligation or stinmlation with 25  nM PMA. MBP phosphorylating 
activities of anti-ERK2 immunoprecipitates from the me ~ and wild-type 
anti-TCR-treated cells were again evaluated by SDS-PAGE and autorad- 
iography, and the results were then quantitated by densitometric analysis 
of the phosphorylated bands. Results are expressed as the fold increase in 
MBP-phosphorylating activity of me' relative to wild-type-derived anti- 
ERK2 immunoprecipitates.  The data shown represent the mean (+_ SEM) 
of values obtained in four independent experiments. 
tivity fell rapidly to basal levels in the normal thymocytes, 
levels of this kinase activity remained markedly increased in 
the  me ~ cells, even at 20 min after cell stimulation. By con- 
trast, the magnitude and kinetics of MAPK activation after 
PMA stimulation were no different in the mutant and con- 
trol cells (Fig. 9  B). Thus, the sustained increases in MAPK 
activity observed in the me v  thymocytes after TCR  stimula- 
tion  cannot  be  ascribed  to  an  intrinsic  abnormality  in 
MAPK  function  per  se,  but  instead  appear  to  reflect  the 
consequence  of defects in upstream molecular interactions 
through which Ras  and  MAPKs are recruited to the anti- 
gen receptor signaling pathway. Irrespective of the mecha- 
nisms  whereby  PTP1C  deficiency perturbs  the  activation 
of Ras/MAPK,  these findings identify PTP1C  as a signal- 
ing element that is potentially involved in the  attenuation 
of the Ras response to TCR  ligation. 
Discussion 
The data reported in this paper indicate a significant role 
for PTP1C  in regulating the T  cell response to antigen re- 
ceptor stimulation, and they suggest that PTP1C  effects on 
the  signaling pathways  evoked by  TCR  engagement  are 
predominantly inhibitory. The data link the negative influ- 
ence of PTP1C  on T  cell signaling to this enzyme's inter- 
actions  with  and  likely dephosphorylation  of the  resting 
and activated TCR  complex components,  as well as vari- 
ous  cytosolic phosphoproteins,  most  notably pp38,  which 
are recruited to the Vav and Grb2 SH2 domains after TCR 
engagement.  The  current  findings  strongly  suggest  that 
these latter phosphoproteins are directly dephosphorylated 
by  PTP1C,  but  do  not  preclude the  possibility that  their 
phosphorylation  state  is  modulated  indirectly by  PTP1C 
through its effects on PTK function, particularly in light of 
recent  data implicating PTP1C  in  the  negative regulation 
of Lck (19) and ZAP-70 (47) activities. While this latter is- 
sue remains to be resolved, the data reported here revealing 
the association of PTP1C  deficiency with enhancement in 
TCR-induced  cellular proliferation, activation of MAPK, 
and tyrosine phosphorylation of TCR  components, as well 
as  Grb2-  and Vav-binding phosphoproteins,  provide bio- 
chemical  and  functional  evidence  that  PTP1C  serves  to 
downregulate the coupling of TCR  stimulation to Ras ac- 
tivation and as such exerts a critical influence on the deliv- 
ery of ligand-binding signals to the nucleus. 
At  the  present  time,  the  structural  basis  for  PTP1C- 
TCR  interaction is unclear, as this association does not ap- 
pear to be substantially altered by receptor engagement and 
is therefore unlikely to be mediated through  PTP1C  SH2 
domain binding to TCR  phosphotyrosine residues. It is also 
unclear whether the increase in constitutive tyrosine phos- 
phorylation of putative TCR  elements detected in me  thy- 
mocytes reflects ligand-independent receptor activation con- 
sequent  to  the  lack  of PTPIC  activity,  or  alternatively, 
enhanced/prolonged  stimulation  of the  TCR  in  vivo  by 
ligands in the thymic environment.  While these issues re- 
main to be resolved, the data strongly suggest that PTPIC 
influence  on  TCR  signaling  is  realized  at  least  in  part 
through the maintenance of the resting TCR  in a tyrosine- 
dephosphorylated state,  a  role  for PTP1C  also  previously 
proposed in relation to its effects on the BCR  (15). 
In  addition to  PTP1C  association with  TCR  subunits, 
the current data also demonstrate the capacity of PTP1C  to 
associate with CD5, a transmembrane protein expressed on 
both thymocytes and T  cells and previously identified as a 
TCR-associated signaling element targeted for PTK-medi- 
ated tyrosine phosphorylation in activated T  cells (30).  In 
contrast  to  TCR-~  and  CD3-e,  CD5  association  with 
PTP1C  was  somewhat  enhanced  in  activated thymocytes 
in the  context of CD5  tyrosine phosphorylation and  may 
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with CD5 phosphowrosine residues.  While this possibility 
requires  further  analysis,  the  association  of PTPIC  with 
CD5 is of particular interest in view of recent data showing 
thymocyte  hyperresponsiveness  to  TCR  stimulation  in 
mice  rendered  genetically  deficient  for  CD5  expression 
(48).  Since these latter data suggest that CD5 acts as a nega- 
tive  regulator  of the  TCR.-mediated  signal  transduction 
events  governing  thymocyte  selection,  the  capacity  of 
PTP1C to associate with and potentially modulate CD5 ty- 
rosine  phosphorylation  status  raises  the  possibility  that 
PTP 1C inhibitory effects on TCR. signaling are relevant to 
the  regulation  of intrathymic  selection  events.  Although 
this  hypothesis  requires  further  investigation,  a  role  for 
PTP1C in regulating TCR-mediated T  cell selection is also 
implied by the current data suggesting that PTP1C acts to 
attenuate  antigen  receptor-triggered  Ras/MAPK  activa- 
tion, a biochemical event recently shown to be required for 
TCR-induced  positive  selection  (45,  46).  Thus,  while 
overt defects in thymocyte maturation were not detected in 
motheaten mice,  the possibility remains that  the  inappro- 
priate activation of P,.as/MAPK pathways caused by PTP1C 
deficiency  alters  TCt<  signal  circuitry  in  a  manner  that 
shifts  the  balance  of positive  and  negative  selection  pro- 
cesses during thymocyte ontogeny. In other words, the ef- 
fects of PTP1C  deficiency on P,  as activity may be associ- 
ated  with  aberrant  maturation  of autoreactive thymocytes 
that are normally subject to intrathymic deletion. It is cur- 
rently  unknown  whether  the  coupling  of TCP,-induced 
Ras activation to selection involves the upstream activation 
of CDS,  but  the  suggested  role  for PTP1C  in  regulating 
TCR-driven thymocyte selection is consistent with the se- 
vere autoimmune syndrome expressed in motheaten mice 
and with previous data revealing an influence of this phos- 
phatase on the signaling events coupling BCR engagement 
not  only  to  cell  proliferation/activation,  but  also  to  pro- 
grammed cell  death  (16,  49).  In addition,  in  view of the 
well-recognized link between aberrant tkas activation and 
malignant transformation, PTP1C  effects on Ras may also 
be relevant to the transformation of lymphoid cells, a possi- 
bility supported by the  increased susceptibility of me"  and 
nle heterozygotes to lymphoproliferative disease (50). 
Although the current data identify.  TCR  components as 
well as pp38  and other Vav- and  Grb2-binding phospho- 
proteins as likely substrates for PTP1C activity in activated 
thymocytes, the  structural  interactions  that  underlie  these 
observations  remain  unclear.  However,  when  considered 
in relation to previous data showing the capacity of PTP1C 
to interact with both Vav and Grb2 (31), as well as the cur- 
rent  data  demonstrating the  binding  of the  Vav SH2  do- 
main with phosphorylated components of the TCFZ, these 
findings  are consistent  with  cumulative data  in  the  litera- 
ture linking intracellular signal transduction to the assembly 
ofmultimeric complexes within which various effectors in- 
teract so as to further propagate the activation signal.  The 
likely juxtaposition  of PTPIC,  Grb2,  and phosphorylated 
subunits of the TCR within this multimeric unit raises the 
possibility  that  PTP1C  functions  in  this  network  in  not 
only a  regulatory capacity,  i.e.,  through  tyrosine  dephos- 
phorylation of other complex components,  but  also  i,1  an 
adaptor fashion, i.e., by providing a link between phosphor- 
ylated TCR. subunits and the Grb2 SH2 domain. The posit 
of an adaptor role for PTP1C provides a molecular expla- 
nation for the mode of Grb2 recruitment into the signaling 
pathway originating from the  TCR,  and is also  consistent 
with previous data revealing the structurally similar Syp ty- 
rosine phosphatase to act as a linker for coupling-activated 
growth factor receptors to Grb2 (5 i). While a similar role is 
also subserved by the SH2 domain-containing Shc protein 
in relation to a number of growth factor receptors (52),  Shc 
does not appear to play a predominant role in linking Grb2 
to the activated TCR, since we (data not shown) and oth- 
ers  (37)  have not detected substantial levels of phosphory- 
lated Shc in Grb2 or Grb2 SH2 domain  precipitates from 
activated  T  cells.  By  contrast,  in  conjunction  with  pub- 
lished data showing Vav and Grb2 association to be medi- 
ated through dimerization of their respective SH3 domains 
(53), the current demonstration ofVav SH2 domain-medi- 
ated interaction with the phosphorylated TCP,. in activated 
thymocytes suggests  that  Vav function  in  T  cell  signaling 
may involve the coupling of Grb2 to the activated receptor 
components. In this context, the reported effects of Vav on 
Ras activity may derive from Vav-mediated enhancement 
of Grb2/mSos association rather than through Vav-induced 
GDP/GTP  exchange  on  Ras,  a  possibility previously in- 
voked to  explain  the  discrepancy between  Vav structural 
properties and putative biologic activity (53).  In any case, 
irrespective of the extent to which Vav and/or PTP1C act 
as  adaptors  in  relation  to  TCR  signal  relay,  the  data  pre- 
sented here suggest  that the contributions of PTP1C  and the 
signaling effectors with which it associates to the propaga- 
tion of TCP,.-derived activation signals  are likely to reflect 
the  capacity  of these  molecules  to  participate  in  divm~e 
combinations  of molecular interactions  and  to  thereby  as- 
sume  more  than  one  function  in  relation  to  signal  relay. 
Accordingly,  the  further  exploitation  of PTPlC-deficient 
mice toward the dissection of PTP1C functions in relation 
to the signaling transducing molecules with which it associ- 
ates represents a promising avenue towards delineating the 
molecular  mechanisms  for  translating  TCR  stimulation 
into a multiplicity of physiologic outcomes. 
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